Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.

@article{Andreyko1988UseOA,
  title={Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.},
  author={J L Andreyko and Zeev Blumenfeld and Lorna A. Marshall and Stephen Monroe and Hedvig Hricak and Robert B. Jaffe},
  journal={American journal of obstetrics and gynecology},
  year={1988},
  volume={158 4},
  pages={903-10}
}
The purposes of this study were to investigate the effect of a superactive agonistic analog of gonadotropin-releasing hormone, nafarelin, on uterine leiomyomas and to assess the use of magnetic resonance imaging in monitoring uterine and myoma size. Eleven women with uterine leiomyomas were treated with 800 micrograms of nafarelin per day for 6 months… CONTINUE READING